Posts Tagged ‘Glycoprotein IIb/IIIa inhibitors’

August 9th, 2010

The GP IIb/IIIa Inhibitor Wars: Not Ready To Surrender


Although two recent studies (EVA-MI and SCAAR) report that eptifibatide is as effective as abciximab with respect to myocardial reperfusion and clinical events in patients undergoing primary PCI, the thoughtful and balanced editorial accompanying them points out that the studies “ought not be considered convincing or as level 1 evidence” that the GP IIb/IIIa inhibitors […]